ICYMI: Cancer death rate continues to decline due to treatment advances

Earlier this month, the American Cancer Society (ACS) released its annual report, Cancer Statistics 2023, finding the overall cancer mortality rate has declined 33% since peaking in 1991, leading to...
Read More
Sparking conversations — and careers — at the 2nd annual Pathways to Success Summit

On September 28-29, 2022, PhRMA hosted the second annual Pathways to Success: Virtual Graduate Summit and Career Expo. This event provided a unique opportunity for students and faculty from diverse...
Read More
How HTA-based price controls could worsen health outcomes and health disparities

Concerns about the cost of health care have led to calls for the use of health technology assessments or HTAs by the federal government. This would allow government agencies to make important...
Read More
Identifying and addressing health disparities: PhRMA's first chart pack on health equity

PhRMA is proud to announce the release of its first ever chart pack on health equity. This chart pack contains information on health equity in three sections: (1) A Snapshot of Health Disparities in...
Read More
New comments outline ways to protect patients from health plans and PBMs who profit from patient assistance

PhRMA submitted comments this week in response to the Department of Health & Human Services (HHS) proposed rule on the Nondiscrimination in Health Programs and Activities. As outlined in our...
Read More
Frazier PhRMA Scholarship awarded to four college-bound students in Philadelphia and DC

The Kenneth C. Frazier PhRMA Scholars Program is going strong in 2022—and we are expanding our horizons to a new city. This summer, we are thrilled to announce four new recipients: Arianna...
Read More
You won’t fix what you don’t value: Two reasons why traditional cost-effective analyses can perpetuate health inequities

A new report from Partnership for Health Analytic Research or PHAR describes how value assessments that use traditional cost-effectiveness analyses can overlook important health disparities and risk...
Read More
Recognizing LGBTQ+ Pride in biopharmaceutical science

June is Pride Month and, like many across the country, we look forward to celebrating the importance of equality and reminding ourselves to continually seek opportunities to make our society more...
Read More
Potential gene therapies bring hope to patients with sickle cell disease

A recent analysis highlights how potential gene therapies have the potential to dramatically reduce income disparities for patients with sickle cell disease, leading to as much as $21,000 more in...
Read More
Addressing social determinants of health to improve equitable access to medicines

PhRMA Awards $150,000 to Address Social Determinants of Health:Announcing the Recipients of Round 4 of the PhRMA Collaborative Actions to Reach Equity (CAREs) Grant Program As part of PhRMA’s...
Read More